In these experiments, we observed that the incidence of VPBs and VT was significantly reduced and that the onset time was delayed when hearts were reperfused with Rb1-containing perfusate (Fig. 7), indicating that Rb1 indeed confers resistance to arrhythmias. The gene discussed is RB1; the disease is cardiac arrhythmia.